विमर्श Vimarsh · Udyamnīti

What a ₹100 Crore Seed Price Was Paid For

Wellpro, the wellness company I co-founded with Dr Ashutosh Rastogi, was priced at ₹100 crore in its first seed round. Not on revenue. On a patent application, a protocol, a portfolio of formulations and a distribution system built in about sixty days. The operational record, what the price did and did not mean, and what a founder can copy.

Nikhil Sharma · उद्यमनीति Udyamnīti · 11 October 2026 · 7 min read

I co-founded Urzano Wellness Private Limited, which trades as Wellpro, and hold a minority stake. Fabulous.Media, which I run, built its store and web properties. This page is the record as the company’s documents state it; it does not publish the company’s revenue, which is the company’s to disclose.

On 25 August 2022 Urzano Wellness Private Limited was incorporated in India. It trades as Wellpro. Its first seed round was priced at ₹100 crore.

That number sits as one line in [my record](/cv). People ask about it more than anything else on the page, and they usually ask the wrong question. They ask how a company with no long sales history could be worth ₹100 crore. The better question is what, exactly, an investor was paying for when they paid that price. The answer is specific, and most of it can be copied.

This is the operational record. Every dated line rests on a document: the company’s incorporation, a patent application, a recognition certificate, the build of its web properties. Where a figure is the company’s private business, it is left out and I say so.

A seed price is not a verdict on what a company has sold. It is a bet on what it owns.

The company, and why it was built this way

Wellpro was built by two people with different instruments. Dr Ashutosh Rastogi brought the protocol and the formulations: more than fifty proprietary herbal nutraceutical formulations and a programme called the Soleus Activation Series. I brought the operating machine: a distribution and brand system from Fabulous.Media, which has built and run growth for brands since 2008. The company was set up from the first day as an owner of things rather than a seller of hours. It holds its formulations, its programme and, from March 2023, a patent application.

The decision that shaped everything after it was to sell through a store and a community rather than through a clinic. A clinic is limited by the doctor’s hours and the doctor’s city. A store and a community are limited only by distribution, which is the part an operator can build. That choice is why the company could be priced like a product business at seed and not like a practice.

Sixty days to a working distribution system

Fabulous.Media built the store and the education platform from scratch in about two months. By March 2023 the company was operating nine web properties: the main site at wellpro.one, the store, the community, the corporate site and a set of programme and content properties, each built to carry one audience from first interest to purchase without handing it to someone else’s platform.

Nine properties sounds like sprawl. It was the opposite. Each one had one job, one audience and one place in the sequence, which meant that each could be measured on its own and switched off on its own. The rule we worked to is the same rule this site argues for in [An Expectation Is Not an Agreement](/soch/vimarsh/an-expectation-is-not-an-agreement): own the relationship with the customer and treat every rented channel as a road, not a contract. A wellness buyer who joins a community and buys from a store you own is an asset on your balance sheet in all but the accounting. A buyer who found you through an ad and left is an expense.

The speed mattered for a reason beyond pride. An investor pricing a seed round is pricing the team’s ability to execute. Nine working properties in the first months of a company’s life is evidence of that ability that no deck can supply. It turned the conversation from what we would build into what we had built.

The patent application and why it changed the price

On 2 March 2023 an Indian patent application, number 202311014252, was filed for the Soleus Activation Series. It names Dr Ashutosh Rastogi and me as inventors and is assigned to the company, which means the company and not either of us owns whatever it protects.

A patent application is not a granted patent and I will not pretend it is one. What it is, at seed, is a filed and dated claim that the company has made something specific enough to describe in law. Investors in wellness see hundreds of companies with a founder, a formula and a story. Very few arrive with a filed application, assigned to the company, for the thing they sell. It moves a company from the category of brands, which are easy to copy, to the category of owners, which are not.

Recognition, and a strategic partner

The company was recognised under the Government of India’s Startup India programme, which confirms that it is a new, innovation-led company under the department’s definitions and opens the scheme’s benefits. It is not an endorsement of the product and should never be sold as one, but it is a public, checkable fact that a diligence team looks for.

In the same quarter as the patent filing, a strategic partner from North America took a small stake in the company. A small stake from a partner in a larger market does two things for a seed company. It is a second, independent price on the business, set by someone who did their own work. And it is an early door to a market where wellness buyers already pay for protocols rather than products.

What the ₹100 crore did and did not mean

Here is the part founders most need to hear. A seed round priced at ₹100 crore means that an investor bought a small percentage of the company at a price that values the whole at ₹100 crore. It does not mean the company had ₹100 crore of anything. It does not mean the founders could sell their shares at that price the next morning. It is a price agreed between willing parties for a small slice, on the evidence available on that day.

I hold a minority stake in Urzano Wellness, as the company’s records show. That is the right structure for this company: the doctor whose protocol is the core of the product holds the majority, and the operator who built the machine holds a stake that rises and falls with the same value. It is also the structure NS Transform offers founders: an operator who carries the build in exchange for a minority holding, rather than for a retainer. Wellpro is the clearest example I have of that model on paper.

I will not publish the company’s revenue here. It is a private company, the figures are its own, and a case study that quotes another company’s numbers without its board’s consent is not a case study, it is a leak. What I can say is what the price was paid for, and that is the useful part.

What a founder can copy

One. Decide at incorporation what the company will own, and write it down. Formulations, a protocol, a method, a dataset. A company that owns nothing can only sell time. Two. File early, and assign to the company. A patent application in the founder’s personal name is a dispute waiting to happen; in the company’s name it is an asset on the term sheet. Three. Build the distribution before you raise. Sixty days of execution is worth more in a seed conversation than sixty slides of intent. Four. Own the customer relationship from the first sale. A community and a store you control are worth more per customer than any channel you rent. Five. Get a second price from a strategic partner if you can. It disciplines the first one. Six. Understand what a valuation is. It is a price for a slice, not a sum in the bank, and the founders who forget that make the worst decisions of their companies’ lives.

The wager

Every essay on this shelf ends on a dated bet. Here is this one. By 11 October 2029, more Indian wellness and nutraceutical companies will raise their first institutional round on the strength of filed intellectual property and an owned community than on the strength of paid-acquisition growth. The era of buying wellness customers through ads and calling it a brand is ending, because the ads are getting dearer and the buyers are getting harder to keep. I will look at the rounds announced in 2028 and 2029 and report what I find.

Gurugram, 11 October 2026.

The record, as the documents state it. Incorporation of Urzano Wellness Private Limited on 25 August 2022, its shareholders and its Startup India recognition: the company’s master data with the Ministry of Corporate Affairs, as quoted in the company’s own records. The seed round at a ₹100 crore valuation and the strategic partner’s stake: the company’s records. Patent application 202311014252, filed 2 March 2023, the Soleus Activation Series, inventors Dr Ashutosh Rastogi and Nikhil Sharma, assigned to Urzano Wellness: the Indian Patent Office record, searchable at ipindia.gov.in. The store built in about two months and nine web properties by March 2023: Fabulous.Media’s build records. Startup India’s definitions: startupindia.gov.in.